AI & Bioscience w/ Miles Harrison (CEO of Conexeu), SK Hynix IPO & Blue Origin Fundraise
July 9, 2026
AI Summary
5 min readIn January, Eli Lilly and Nvidia announced a billion-dollar AI-powered drug discovery lab. In May, Google's Isomorphic Labs raised $2.1 billion to push AI-designed drug candidates into clinical trials. And biotech M&A hit $106 billion year-to-date, on pace for the best year since before COVID. Miles Harrison, CEO of Conexeu (ticker CNXU), is building at this exact intersection. Harrison previously ran Galderma's North American business, scaling Cetaphil from $1.2 billion to over $2.1 billion in revenue, and co-founded an aesthetics company that sold in an eight-figure exit. Now he's leading a company developing a patented collagen-based tissue regeneration platform, and he argues that AI is about to transform biotech in ways software never could.
Why AI Changes the Game for Biotech
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
Never miss an episode of Rich Habits Podcast
Get every new episode summarized in your inbox — free, ~5 minutes to read.
No spam. Unsubscribe anytime.
What you'll learn
- 1 (00:00) **Episode Intro & Ad Break** - Hosts Austin Hankwitz and Robert Croak preview the three radar topics: Iran ceasefire, SK Hynix IPO, and US Treasury AI bubble warning, then introduce the main interview segment.
- 2 (02:08) **Interview: AI & Biotech with Miles Harrison (CEO of Conexeu)** - Miles Harrison, CEO of Conexeu (CNXU), discusses the intersection of AI and biotechnology, and the GLP-1 tailwind.
- 3 (23:40) **Radar Point #1: Iran Ceasefire Over** - Trump declares the 60-day ceasefire with Iran dead after attacks on tankers and US retaliation.
- 4 (27:34) **Radar Point #2: SK Hynix IPO** - SK Hynix (SKHY) begins trading on the Nasdaq, aiming to raise $28 billion.
- 5 (34:38) **Radar Point #3: US Treasury Warns of AI Bubble** - A leaked internal Treasury report compares the current AI market to the dot-com bubble, warning of systemic risk.
- 6 (43:14) **Radar Points: Quick Hits** - Hosts share three rapid-fire radar points each.
- 7 Standout Quotes
+ Full timestamped outline available in the app
Show Notes
Friday on a Thursday!
We're joined by Miles Harrison, CEO of Conexeu Sciences (Nasdaq: CNXU), to discuss the intersection of AI and bioscience + how GLP-1s are carving out a new market for them.
---
🚀 Invest alongside Robert and Austin inside the Rich Habits Network, click here!
---
🤖 VCX: the public ticker for private tech -- click here or visit https://getvcx.com/ to learn more!
---
📸 Join us on Friday, July 10 at 12p ET for our AI Agents webinar with Public!
https://www.crowdcast.io/c/aiagents
We're thrilled they're workshopping agents with us, and can't wait to learn from Stephen Sikes.
---
🏆 Wall Street Favorites is LIVE! Click here to see what Wall Street is buying before everyone else.
---
🧠 Ready to build your own investable index using AI? Generated Assets on Public makes it easy.
Click here to try Generated Assets!
---
🚀 Join 900+ other podcast listeners inside of the Rich Habits Network and invest alongside Robert and Austin, click here!
---
⚡️ Sign up for the Rich Habits Newsletter and never miss a market-moving headline again, click here!
---
⭐ Download our FREE Financial Planner –
More from this podcast
Rich Habits Podcast →